Dermetel's comprehensive team of experts in internal medicine, gastroenterology, and dermatology and its volunteer staff have worked tirelessly for the past three years spearheading an enzyme replacement therapy solution for those with a rare metabolic disease. Thanks to generous support from Dermetel's corporate sponsors, we are able to fund this and run three trials simultaneously in the United States, Poland, and South Korea, staffed by passionate health activists and trained clinical trials professionals. We are working on doing a trial in the United Kingdom, as well. Please use the Google Form below to register your interest and more information (HIPAA waivers, etc.) will be sent to you via email from our clinical study coordinator. The trial is completely free for participants with an official diagnosis. We anticipate getting cleared approval from South Korea first and by the end of this year.